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Summary
Defects in the endosomal-lysosomal pathway have
been implicated in a number of neurodegenerative dis-
orders [1]. A key step in the endocytic regulation of
transmembrane proteins occurs in a subset of late-
endosomal compartments known as multivesicular
bodies (MVBs), whose formation is controlled by en-
dosomal sorting complex required for transport
(ESCRT) [2, 3]. The roles of ESCRT in dendritic mainte-
nance and neurodegeneration remain unknown. Here,
we show that mSnf7-2, a key component of ESCRT-III,
is highly expressed inmostmammalian neurons. Loss
of mSnf7-2 in mature cortical neurons caused retrac-
tion of dendrites and neuronal cell loss. mSnf7-2 binds
to CHMP2B, another ESCRT-III subunit, in which a rare
dominant mutation is associated with frontotemporal
dementia linked to chromosome 3 (FTD3). Ectopic
expression of the mutant protein CHMP2BIntron5 also
caused dendritic retraction prior to neurodegenera-
tion. CHMP2BIntron5 was associated more avidly than
CHMP2BWT with mSnf7-2, resulting in sequestration
of mSnf7-2 in ubiquitin-positive late-endosomal vesi-
cles in cortical neurons. Moreover, loss of mSnf7-2
or CHMP2BIntron5 expression caused the accumulation
of autophagosomes in cortical neurons and flies.
These findings indicate that ESCRT-III dysfunction is
associated with the autophagy pathway, suggesting
a novel neurodegeneration mechanism that may have
important implications for understanding FTD and
other age-dependent neurodegenerative diseases.
Results and Discussion
mSnf7-2 Is Highly Expressed in Mammalian Neurons
Shrub, the fly ortholog of the yeast ESCRT-III subunit
Snf7 [4], is required for the proper dendritic morphogen-
esis in Drosophila [5, 6]. There are three human Snf7 or-
thologs (hSnf7-1, hSnf7-2, and hSnf7-3) [7, 8] and two
uncharacterized mouse Snf7 orthologs (mSnf7-2 and
mSnf7-3). To understand the function of mSnf7-2 in
mammalian neurons, we first found that mSnf7-2 was
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and in most adult tissues (Figure 1A). mSnf7-2 has 224
amino acids and at least four predicted coiled-coil do-
mains (Figure 1B). From the BayGenomics Consortium
[9], we identified an ES cell line in which the gene-trap
vector is inserted in the last intron (Figure 1C) and gen-
erated heterozygous mSnf7-2 knockout mice that ex-
press a fusion protein consisting of the first 203 amino
acids of mSnf7-2 and b-galactosidase (b-gal); therefore,
the expression of b-gal is under the control of the endog-
enous mSnf7-2 promoter. b-gal staining revealed that
mSnf7-2 is expressed in all layers of the cerebral cortex
(Figure 1D). In the hippocampus, an intense signal was
observed in neurons in CA1, CA3, and the dentate gyrus
(Figure 1D). In the cerebellum, mSnf7-2 was highly ex-
pressed in Purkinje cells that elaborate extensive den-
dritic trees; surprisingly, it was not detectable in granule
neurons (Figure 1E), indicating a neuronal-subtype-
specific function. mSnf7-2 expression was also promi-
nent in the gray matter of the spinal cord (Figure 1F).
Thus, mSnf7-2 appears to have a specific function in
many but not all mammalian neurons.
mSnf7-2 knockout mice died on embryonic day (E)
7.5–8.5. Therefore, we investigated the function of
mSnf7-2 in cultured cortical neurons. First, we gener-
ated a rabbit polyclonal antibody that readily detected
mSnf7-2 but not mSnf7-3. In wild-type mouse brain ly-
sates, it recognized a w35 kDa protein that was 50%
less abundant in brain lysates of heterozygous mSnf7-
2mice (Figure 1G). The mSnf7-2 protein was also readily
detected in lysates of cultured cortical neurons
(Figure 1H).
To determine the subcellular localization of mSnf7-2 in
neurons, we analyzed the nuclear, cytosolic, and mem-
brane fractions of lysates from E18 mouse brains.
mSnf7-2 was found mostly in the cytosolic and the
membrane fractions (Figure 1I). In TUJ1-positive 13
DIV cortical neurons permeabilized with 0.05% saponin
(Figures 1J–1L), endogenous mSnf7-2 showed a mostly
diffuse pattern in the cell body and dendrites (Figures
1M–1O). mSnf7-2 was also detected in the nucleus of
mature neurons at 13 DIV when Triton X-100 was used
to permeabilize the cells (J.L., unpublished data).
mSnf7-2 Is Required for Dendritic Integrity
and Survival of Mature Cortical Neurons
To further examine mSnf7-2 function, we generated
mSnf7-2 siRNAs that could effectively and specifically
downregulate the expression of transfected mSnf7-2-
Myc (Figure S1 in the Supplemental Data available on-
line and Figure 2A). The immunostaining signal detected
by the mSnf7-2 peptide antibody in cultured cortical
neurons was lost 2 days after transfection with
mSnf7-2 siRNA (533–551) (Figures 2B–2D), indicating
that the antibody recognizes endogenous mSnf7-2 in
cortical neurons and further confirming the efficiency
of mSnf7-2 siRNA.
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(A) Northern-blot analysis of mSnf7-2 mRNA expression in different adult mouse tissues.
(B) mSnf7-2 contains 224 amino acids with at least four predicted coiled-coil (CC) domains.
(C) Schematic of the genomic organization of mSnf7-2. b-gal was inserted in the last intron and under the control of the endogenous mSnf7-2
promoter.
(D) The expression pattern of mSnf7-2 in adult mouse brain, as shown by the b-gal staining.
(E) mSnf7-2 is highly expressed in Purkinje cells but not in granule neurons in the cerebellum.
(F) mSnf7-2 is expressed mostly in the gray matter of the spinal cord.
(G) The mSnf7-2 peptide-specific antibody recognizes mSnf7-2 in mouse brain lysates in western blotting.
(H) This antibody also recognizes mSnf7-2 from lysates of cortical neuron cultures.
(I) mSnf7-2 is mostly present in the cytosolic (C) and membrane (M) fractions isolated from E18 mouse brains. ‘‘N’’ stands for nuclear
fraction.
(J) Cortical neurons at 13 DIV were labeled with an antibody for TUJ1, a neuron-specific b-tubulin.
(K and N) Detection of mSnf7-2 in the cell body and neurites of cortical neurons.
(L) Merged image from (J) and (K).
(M) MAP2 labeling of neuronal cell body and dendrites of cultured cortical neurons.
(O) Merged image from (M) and (N). The scale bar represents 10 mm. In all immunostaining experiments, the cell membrane was permeabilized
with 0.05% saponin. When mature neurons at 13 DIV were permeabilized with Triton X-100, mSnf7-2 was also detected in the nucleus
(J.L., unpublished data).To examine the roles of mSnf7-2 in dendritic develop-
ment, we transfected mSnf7-2 siRNA (533–551) into
three DIV cortical neurons. Dendritic branching failed
to elaborate properly in those cells, but the reduced
mSnf7-3 activity transiently increased dendritic branch-
ing of developing neurons (J.L., unpublished data). To
determine whether mSnf7-2 is required to maintain
mature dendritic trees, we transfected mSnf7-2 siRNA
(533–551) or mSnf7-2 siRNA (482–500) into 15 DIV ma-
ture cortical neurons that exhibit fully elaborateddendritic trees. Two days later, the dendritic trees of
transfected neurons had retracted dramatically, as
quantified by MAP-2 staining (Figures 2G and 2I). As
controls, a scrambled siRNA construct (Figure 2F) or
a mutantmSnf7-2 siRNA (533–551) that did not suppress
mSnf7-2 expression (Figure S1) had no effect. Moreover,
we performed a rescue experiment with an mSnf7-2
construct that expresses wild-type mSnf7-2 but is not
a target formSnf7-2 siRNA (533–551) (Figure 2E and Fig-
ure S1B). Cotransfection of 15 DIV cortical neurons with
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(A) Generation of mSnf7-2- and mSnf7-3-specific siRNA that effectively suppresses the expression of mSnf7-2-Myc or mSnf7-3-Myc, respec-
tively, in transfected HEK293 cells as detected in western blotting with Myc antibody.
(B) A cortical neuron expressing mSnf7-2 siRNA and GFP.
(C) Immunostaining indicates that the siRNA construct greatly suppresses the expression of endogenous mSnf7-2.
(D) Merged image from (B) and (C). Arrows (B–D) indicate a neuron expressing mSnf7-2 siRNA. The scale bar for (B)–(D) represents 10 mm.
(E) Western-blot analysis confirms that the mSnf7-2* construct is resistant to mSnf7-2 siRNA (533–551).
(F) An 18 DIV cortical neuron 2–3 days after transfection with scrambled siRNA.
(G) An 18 DIV cortical neuron 2–3 days after transfection with mSnf7-2 siRNA.
(H) Rescue of the effect of mSnf7-2 siRNA (533–551) on dendritic trees by an mSnf7-2 construct that expresses wild-type mSnf7-2 and whose
mRNA is resistant to the siRNA (mSnf7-2*). Scale bars for (F)–(H) represent 20 mm.
(I) Quantification of total MAP2-positive dendritic length of 18 DIV cortical neurons 2 days after transfection with scrambled siRNA (n = 20),
mSnf7-2 siRNA (533–551) (n = 24), or the rescue construct together with mSnf7-2 siRNA (n = 16). ***p < 0.001.
(J) Effect of loss of mSnf7-2 on the survival of mature cortical neurons. Values are the mean 6 SEM of four independent experiments for each
experimental condition, except mSnf7-3, in which three independent experiments were performed. ***p < 0.001.this construct and mSnf7-2 siRNA (533–551) rescued the
dendritic phenotype (Figures 2H and 2I), indicating that
this phenotype was not due to the off-target effects of
the siRNA.
mSnf7-2 was also required for neuronal viability. By 3
days after transfection with mSnf7-2 siRNA (533–551),
50% of transfected mature cortical neurons (15 DIV)
were lost, as judged by the reduced number of GFP-
positive and PI-negative neurons (Figure 2J). More im-
portantly, the cell-loss phenotype could be rescued
(Figure 2J) by cotransfection of the rescue construct
that expressed wild-type mSnf7-2 but was resistant
to mSnf7-2 siRNA (533–551) (Figure 2E). Control
neurons transfected with a scrambled siRNA, mutated
mSnf7-2 siRNA (533–551), or mSnf7-3 siRNA (418–436)
(Figure S1D) were not affected at day 3 after transfection
(Figure 2J).CHMP2BIntron5 Causes Rapid Neuronal Cell Loss
in Cultured Cortical Neurons
To further dissect the role of ESCRT-III in postmitotic
neurons, we examined other mammalian ESCRT-III
components. CHMP2B, the human ortholog of the yeast
ESCRT-III subunit Vps2, is particularly interesting. A sin-
gle splice-site mutation in CHMP2B is associated with
autosomal dominant frontotemporal dementia linked
to chromosome 3 (FTD3) in a Danish family [10, 11].
The fact that this splice-site mutation is rare in FTD pa-
tients, and nonpathogenic mutations in CHMP2B were
also reported [11], highlights the need to understand
the molecular mechanisms underlying the neurotoxic ef-
fects of some but not other mutant CHMP2B proteins.
FTD, the second most common form of dementia in pa-
tients that are under 65 years old, results from extensive
focal degeneration of frontal and temporal lobes and
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1564Figure 3. CHMP2BIntron5 Causes Dendritic Retraction and Neurodegeneration in Cultured Cortical Neurons through Interfering ESCRT-III
Dissociation
(A) Schematics of wild-type (CHMP2BWT) and mutant CHMP2B proteins. ‘‘CC’’ stands for coiled-coil domain. The asterisk indicates D148Y. The
black box represents an abnormal 29 amino acid C terminus of CHMP2BD10.
(B) Survival curves of cultured cortical neurons transfected with EGFP alone or with different CHMP2B proteins. Values are the mean6 SEM of
four independent experiments. ***p < 0.001.
(C) The effects of wild-type or mutant CHMP2B proteins on dendritic morphology of 15 DIV mature cortical neurons. Different CHMP2B proteins
were cotransfected with GFP, and the dendritic length was measured by MAP2-antibody staining. The scale bar represents 20 mm.
(D) The expression of different CHMP2B mutant proteins in HEK293 cells 18 or 72 hr after transfection. Flag antibody was used for detecting
wild-type or mutant CHMP2B proteins. b-tubulin served as the loading control.
(E) Coimmunoprecipitation of endogenous Snf7-1 with Flag-CHMP2BIntron5 or CHMP2BWT in HEK293 cells 48 hr after transfection. Cell lysates
were immunoprecipitated with mSnf7-2 antibody, and western blotting was performed with Flag antibody. Three independent experiments were
performed.
(F) Localization of endogenous mSnf7-2 in mature cortical neurons 48 hr after transfection with CHMP2BWT or CHMP2BIntron5. CHMP2BWT did
not completely colocalize with endogenous mSnf7-2 because of its overexpression. Arrows indicate the abnormal distribution of mSnf7-2. The
scale bar represents 10 mm.causes dramatic changes in social and behavioral func-
tions [12, 13]. FTD is clinically distinct from Alzheimer’s
disease and has a highly heterogeneous genetic basis
[14, 15]. The rare splice-site mutation in CHMP2B re-
sulted in abnormal mRNA splicing and production of
mutant proteins that either lack the last 36 amino acids
at the C terminus with the last amino acid methionine
changed to valine (CHMP2BIntron5) or have an abnormal
29 amino acid C terminus (CHMP2BD10) (Figure 3A). A
missense mutation (CHMP2BD148Y) with unknown func-
tional significance was also reported (Figure 3A).
To determine whether mutant CHMP2B proteins
cause neurodegeneration, we coexpressed GFP and
Flag-tagged mutant forms of CHMP2B in 15 DIV cortical
neurons. Two to three days after transfection, neuronal
cell loss was considerably increased only in neurons ex-
pressing CHMP2BIntron5 (Figure 3B). Neurons express-
ing Flag-CHMP2BWT or Flag-CHMP2BD148Y showed
only a slight reduction in viability by day 2, suggestingthat the D148Y mutation is not pathogenic (Figure 3B).
Neurons expressing Flag-CHMP2BD10 or GFP alone
had no phenotype (Figure 3B). Similar results were ob-
tained in cells transfected with untagged CHMP2B con-
structs (data not shown). These findings suggest that
CHMP2BIntron5 is sufficient to cause neurodegeneration
and that not all CHMP2B mutant forms are pathogenic.
The total dendritic length of mature cortical neurons
was unaffected 1 day after transfection with Flag-
CHMP2BIntron5, as quantified by MAP-2-antibody stain-
ing; however, by day 2, Flag-CHMP2BIntron5 but not
other mutants caused severe dendrite loss in surviving
neurons (Figure 3C), indicating that dendritic loss oc-
curs before the neuronal-cell-loss phenotype become
apparent. To demonstrate that the differences in the ef-
fects of mutant CHMP2B proteins were not due to differ-
ent expression levels, we performed immunostaining
with the Flag antibody and found no obvious difference
in the expression levels of Flag-CHMP2BWT and other
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fection (data not shown). Moreover, we transfected
identical amounts of wild-type and different mutant
Flag-CHMP2B constructs into HEK293 cells. No differ-
ence in protein expression levels was observed 1 day
after transfection (Figure 3D). By day 3, however, Flag-
CHMP2BD10 was barely detectable (Figure 3D). Indeed,
Flag-CHMP2BD10 was less stable than other forms of
CHMP2B in a protein turnover assay (Figure S2). There-
fore, in the following studies, we focus on CHMP2BIntron5
only.
CHMP2BIntron5 Causes Neurodegeneration
through Its Failure to Dissociate from ESCRT-III
At least three distinct mechanisms may explain why ec-
topic expression of CHMP2BIntron5 or loss of the ESCRT-
III subunit mSnf7-2 led to rapid neuronal cell loss in cul-
tured cortical neurons. First, CHMP2BIntron5 may have
a dominant-negative effect on endogenous CHMP2B,
causing a loss of CHMP2B function that results in
neuronal cell loss. Second, CHMP2BIntron5 may self-
aggregate, causing neuronal cell loss independent of
ESCRT-III. Third, CHMP2BIntron5 may affect either or
both association and dissociation of ESCRT-III.
To investigate these possibilities, we found that
CHMP2B siRNA (578–596) (Figure S1E) did not affect
neuronal cell survival 3 days after transfection, unlike
the loss of mSnf7-2 (Figure S3), indicating that
CHMP2BIntron5 neurotoxicity is probably not due to
a dominant-negative effect on endogenous CHMP2B.
To test the second possibility, we tagged CHMP2BWT
and CHMP2BIntron5 with both Myc or Flag epitopes,
separately, and found that similarly to CHMP2BWT,
CHMP2BIntron5 did not associate with itself (Figure S4),
although both could associate readily with mSnf7-2
(Figure 3E).
ESCRT-III subunits are present either separately in the
cytosol or as a complex on endosomal membranes, and
ESCRT-III dissociation prior to the next round of sort-
ing is essential for MVB formation [2, 3]. In HEK293 cells,
the same amount of endogenous human Snf7-1 pulled
down approximately 3.5 times more Flag-CHMP2BIntron5
than Flag-CHMP2BWT (Figure 3E), indicating that
CHMP2BIntron5 fails to dissociate from ESCRT-III prop-
erly. Indeed, 2 days after transfection into 15 DIV mature
cortical neurons, Flag-CHMP2BIntron5 but not Flag-
CHMP2BWT sequestered endogenous mSnf7-2 in vesic-
ular structures (Figure 3F) that are Rab7 positive
(Figures S5A–S5F). Indeed, intracellular sorting or deg-
radation of cargo proteins such as NR1 and EGFR
were affected by loss of mSnf7-2 or CHMP2BIntron5 ex-
pression (Figure S6). These findings indicate that the
FTD3-associated mutation alters the dissociation of
CHMP2B from other subunits, leading to the formation
of dysfunctional ESCRT-III on late endosomes.
To provide additional evidence for the roles of
dysfunctional ESCRT-III in neurodegeneration, we pre-
vented ESCRT-III dissociation from endosomal mem-
branes in cortical neurons by expressing a dominant-
negative form of SKD1, the AAA-family ATPase required
for the dissociation of ESCRT-III [7, 16–18]. Mutant
SKD1 (Figures S5J–S5L), but not the wild-type protein
(Figures S5G–S5I), caused Flag-CHMP2BWT and endog-
enous mSnf7-2 to accumulate in vesicular structures incortical neurons; this phenotype is identical to that
caused by CHMP2BIntron5. As expected, mutant SKD1
caused a rapid loss of cultured cortical neurons (Fig-
ure S5M), further supporting the notion that ESCRT-III
dysfunction, caused by its failure to assemble or to dis-
sociate, leads to neuronal cell loss in cultured cortical
neurons.
CHMP2BIntron5 Expression or Loss of mSnf7-2
Causes Autophagosome Accumulation
In identifying the cell-death pathway responsible for
neurodegeneration as a result of ESCRT-III dysfunction,
we found that TUNEL staining was negative in neurons
expressing CHMP2BIntron5 or mSnf7-2 siRNA. The apo-
ptosis inhibitor Z-vad-fmk inhibited neuronal cell loss in-
duced by glutamate but not by ESCRT-III dysfunction
(Figure S7). Although we cannot rule out the possibility
that apoptosis is involved in late stages of ESCRT-III
dysfunction-induced neurodegeneration in vivo, our
findings raise the possibility that neuronal cell loss in
our assay system involves other mechanisms.
Therefore, we investigated whether CHMP2BIntron5-
induced neurodegeneration is associated with the au-
tophagy pathway [19, 20]. We first expressed GFP-LC3
at a relatively low level as a marker for autophagosomes
[21, 22]. GFP-LC3-positive autophagosomes appeared
in neurons expressing mSnf7-2 siRNA (533–551) or
CHMP2BIntron5 (Figure 4A); interestingly, this occurred
after the appearance of ubiquitylated-protein-contain-
ing vesicles (Figure 4A) and could be prevented by the
autophagy inhibitor 3-methyladenine (Figure S8). We
could not generate CHMP2BIntron5-containing lentiviral
particles from HEK-FT cells, probably because of its
cell toxicity. Therefore, we transfected HEK293 cells
with CHMP2BIntron5 DNA plasmids and also observed in-
creased LC3 and LC3-II levels (Figure 4B) and the accu-
mulation of autophagosomes by electron microscopy
(EM) analysis (Figure 4C). We generated lentiviral parti-
cles expressing mSnf7-2 siRNA and found that reduced
mSnf7-2 activity caused an increase in LC3 and pro-
cessed LC3-II levels in cortical neurons (Figure 4D).
EM analysis showed that MVBs could be easily found
in scrambled siRNA-transfected cortical neurons (Fig-
ure 4E) but is absent in neurons infected with mSnf7-2
siRNA lentivirus; instead, multilamellar bodies and auto-
phagosomes that resemble those reported by others
[19, 20] accumulate massively (Figure 4F). To confirm
these findings in an in vivo system, we performed similar
experiments in a fly eye model of neurodegeneration [23,
24]. We expressed CHMP2BIntron5 or shrub siRNA spe-
cifically in the eye under the control of GMR-Gal4 and
observed the accumulation of autophagosomes in pho-
toreceptor neurons as well (Figure 4G).
In summary, the ESCRT-III component mSnf7-2
is highly expressed in most but not all neurons and is
essential for neuronal structural integrity and viability.
Interestingly, CHMP2B itself is not required for neu-
ronal viability, probably compensated by its paralog
CHMP2A. However, CHMP2BIntron5 found in a rare
form of FTD forms abnormal complexes containing its
normal sister subunit mSnf7-2, resulting in the failure
of ESCRT-III to dissociate from endosomal membranes
and rapid neuronal cell loss, suggesting a novel mecha-
nism of neurodegeneration.
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somes
(A) GFP-LC3-positive autophagosomes form in cultured cortical neurons transfected with mSnf7-2 siRNA (533–551) or CHMP2BIntron5. The left
column shows neurons immunostained with FK2 antibody to detect ubiquitylated proteins. The middle column of panels shows the neurons
cotransfected with GFP-LC3. In control neurons without any transfection (or 48 hr after transfection with CHMP2BWT), LC3 is diffusely expressed
in the cell. The scale bar represents 10 mm.
(B) Western-blot analysis of LC3 expression in HEK293 cells. CHMP2BIntron5 is toxic to cells, resulting in a decreased total protein amount;
therefore, the relative level of LC3 is significantly increased.
(C) EM analysis of autophagosome formation in GFP- or CHMP2BIntron5-transfected HEK293 cells.
(D) Western-blot analysis of LC3 expression in cultured cortical neurons after infection with lentivirus expressing scrambled or mSnf7-2 siRNAs.
(E) EM image of an MVB (yellow arrow) in a scrambled siRNA-transfected cortical neuron.
(F) Cluster of autophagosomes (red arrows) in cortical neurons expressing mSnf7-2 siRNA.
(G) EM images of autophagosome accumulation in fly eyes (red arrows). The expression of CHMP2BIntron5 and shrub RNAi was driven by the
GMR-Gal4. Scale bars for EM images represent 1.0 mm.Multiple lines of evidence from our studies indicate
that ESCRT-III dysfunction caused by loss of mSnf7-2
or CHMP2BIntron5 expression leads to the accumulation
of autophagosomes in neurons, consistent with the
observation that abnormal membranous vesicles form
after the depletion of ESCRT-I components in HeLa
cells [25]. Because autophagic vacuole maturation re-
quires fusion with MVBs [26], ESCRT-III dysfunction is
likely to interfere with this fusion step. Indeed, we found
that GFP-LC3-positive autophagosomes induced by
ESCRT-III dysfunction did not colocalize with lyso-
tracker (J.L., unpublished data). Although loss of basal
autophagy causes neurodegeneration [27, 28], the exact
roles of autophagosomes in age-dependent neurode-
generative diseases or other conditions remain a matter
of debate [19, 20]. Our findings suggest that excess ac-
cumulation of autophagosomes caused by ESCRT-IIIdysfunction is likely to contribute to the pathogenesis
of FTD and possibly to other age-dependent neurode-
generative disorders as well.
Supplemental Data
Experimental Procedures, eight figures, and two tables are available
at http://www.current-biology.com/cgi/content/full/17/18/1561/
DC1/.
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Note Added in Proof
On the basis of our latest sequence database search and analysis,
we call the two mouse orthologs of the yeast protein Snf7 mSnf7-2
and mSnf7-3, which correspond to the human proteins hSnf7-2/
CHMP4B and hSnf7-3/CHMP4C, respectively. In the originally pub-
lished online version of this paper, mSnf7-2 was called mSNf7-2.
